Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Ferry

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Journal of Chromatography. B, Biomedical Sciences and Applications|October 8, 1999
High-performance liquid chromatographic method for sensitive determination of the alkylating agent CB1954 in human plasmaD Anderson, D R Ferry, R J Knox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibitionD R Ferry, A Smith, J Malkhandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Hepatocellular carcinomaS A Hussain, D R Ferry, G El-Gazzaz, et al.
Journal of the American Geriatrics Society|July 15, 1999
Comparison based on age of baseline electrocardiographic abnormalities in non-Q-wave myocardial infarction. VANQWISH Trial Research Investigators. Veterans Affairs Non-Q-Wave Infarction Strategies In-HospitalH G Stratmann, R E Kleiger, D R Ferry, et al.
Journal of the American College of Cardiology|June 1, 1985
Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery diseaseM J Kern, M A Petru, D R Ferry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetinP J Mulholland, D R Ferry, D Anderson, et al.
International Journal of Oncology|June 4, 1998
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancerC V Christodoulou, D R Ferry, D W Fyfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.
Thorax|September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancerS M Lee, L E James, W Qian, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal of Chromatography. B, Biomedical Sciences and Applications|October 8, 1999
High-performance liquid chromatographic method for sensitive determination of the alkylating agent CB1954 in human plasmaD Anderson, D R Ferry, R J Knox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1996
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibitionD R Ferry, A Smith, J Malkhandi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Hepatocellular carcinomaS A Hussain, D R Ferry, G El-Gazzaz, et al.
Journal of the American Geriatrics Society|July 15, 1999
Comparison based on age of baseline electrocardiographic abnormalities in non-Q-wave myocardial infarction. VANQWISH Trial Research Investigators. Veterans Affairs Non-Q-Wave Infarction Strategies In-HospitalH G Stratmann, R E Kleiger, D R Ferry, et al.
Journal of the American College of Cardiology|June 1, 1985
Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery diseaseM J Kern, M A Petru, D R Ferry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetinP J Mulholland, D R Ferry, D Anderson, et al.
International Journal of Oncology|June 4, 1998
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinomaL W Seymour, S P Olliff, C J Poole, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancerC V Christodoulou, D R Ferry, D W Fyfe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpointsD R Ferry, M Deakin, J Baddeley, et al.
Thorax|September 13, 2008
Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancerS M Lee, L E James, W Qian, et al.
Pageof 8